Transfer of value in France: publication of the regulatory provisions specifying the ceilings above which an authorization from the authorities is required

Written By

alexandre vuchot module
Alexandre Vuchot

Partner
France

I'm a partner in our international Commercial group, based in Paris, where I provide our clients with strategic commercial advice.

An important change to the new regime governing transfer of value to HCPs, students and associations will enter into force on 1 October 2020. This change involves the submission procedure to the authorities, which will now differ depending on the value of the advantage in question:

– a declaration procedure for advantages under the ceilings set by a regulatory text (arrêté),

– an authorization procedure for advantages above said ceilings.

For further information on the new legal regime, see our previous post – here – analysing the “anti-gift decree” published last June.

The regulatory provisions (“arrêté”) specifying said ceilings have been published on 14 August.

Click here to read the full article on BioTalk >

 

Latest insights

More Insights
featured image

Europe's medicine supply crisis: How the EU's bold new act aims to address supply chain vulnerabilities

3 minutes May 14 2025

Read More
featured image

UK Court of Appeal reaffirms no UK SPC for second medical use

4 minutes May 14 2025

Read More
featured image

The European Commission’s draft for a Critical Medicines Act (CMA): Disruptive Changes in Public Procurement?

4 minutes May 13 2025

Read More